July 12th 2010 | Children, Psoriasis Research, Treatment, psoriatic arthritis | 0 Comments
Treating psoriasis and/or psoriatic arthritis during pregnancy is often made more challenging by the limited data available for evaluating the potential impact of various treatments on the developing baby. Since 2005, the Autoimmune Diseases in Pregnancy Research Study has been looking for answers. The purpose of the research study is to find out more information
READ THE FULL POST
July 9th 2010 | Psoriasis Research, Treatment, psoriatic arthritis | 0 Comments
As a Korean War-era drug that long ago became a generic, methotrexate has missed out on much of the modern clinical trial research that guides our thinking about more recent treatments. But this workhorse drug is still commonly prescribed for psoriasis and psoriatic arthritis (among other diseases), making continued research on it quite valuable.
READ THE FULL POST
June 20th 2010 | Psoriasis Research, Triggers/environment, psoriatic arthritis | 0 Comments
Break out the bubbly? A Dutch study presented at the Annual Meeting of the European League Against Rheumatism (EULAR) [June 2010 in Rome] found that “alcohol consumption appears to be associated with a reduced risk of developing several forms of arthritis,” according to a WebMD summary of the study. But other research has
READ THE FULL POST
May 26th 2009 | Biologics, Treatment, psoriatic arthritis | 0 Comments
On April 24, the U.S. Food and Drug Administration (FDA) approved Simponi (golimumab) for the treatment of three forms of arthritis, including active psoriatic arthritis. Described in media reports as a “potential blockbuster drug,” Simponi is administered once monthly via injection under the skin. As WebMD put it: “Simponi is in a
READ THE FULL POST
